Background
Non-melanoma skin cancers such as squamous cell
carcinomas and basal cell carcinomas can be treated using a variety of methods,
but surgery remains the principal form of treatment used. As incomplete tumor excision
portends a potentially increased risk of tumor recurrence, ensuring
that skin cancers are adequately excised remains a primary goal of our
surgeons.
Clinical Indicator
Rate
of Incomplete Tumor Excision
Our
rates of incomplete tumor excision for both Basal Cell Carcinomas as
well as Squamous Cell Carcinomas show that we are consistently below the target
of 4%. This demonstrates that the experience of our surgeons, along with
adherence to recommended excision margins has been allowing us to achieve favorable incomplete tumor excision
rates.
Results:
|
2019 Quarters
|
Incomplete Tumor Excision Rate
|
Jan - Mar
|
0.0%
|
Apr - Jun
|
0.5%
|
Jul - Sep
|
0.0%
|
| Oct - Dec |
0.0% |
< Go to Skin Cancer Clinic page